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Amanda R. van Buul1*, Marise J. Kasteleyn1,2, Niels H. Chavannes2 and Christian Taube1,3Abstract
Background: Patients with chronic obstructive pulmonary disease (COPD) experience symptoms that vary over the
day. Symptoms at the start of the day might influence physical activity during the rest of the day. Therefore,
physical activity during the course of the day was studied in patients with low and high morning symptom scores.
Methods: This cross-sectional observational study included patients with moderate to very severe COPD. Morning
symptoms were evaluated with the PRO-morning COPD Symptoms Questionnaire (range 0–60); the median score
was used to create two groups (low and high morning symptom scores). Physical activity was examined with an
accelerometer. Activity parameters during the night, morning, afternoon and evening were compared between
patients with low and high morning symptom scores using independent t-tests or Mann-Whitney U tests.
Results: Seventy nine patients were included. Patients were aged (mean ± SD) 65.6 ± 8.8 years with a mean forced
expiratory volume in 1 s of 55 ± 17%predicted. Patients with low morning symptom scores (score < 17.0) took more
steps in the afternoon (p = 0.015) and morning (p = 0.030). There were no significant differences during the evening
and night.
Conclusion: Patients with high morning symptom scores took significantly fewer steps in the morning and afternoon
than those with low morning symptom scores. Prospective studies are needed to prove causality between morning
symptoms and physical activity during different parts of the day.
Keywords: Afternoon, Chronic obstructive pulmonary disease, Evening, Physical activity, Morning, Morning symptomsBackground
Chronic obstructive pulmonary disease (COPD) is a
worldwide problem with a high prevalence of years lived
with disability [1]. COPD is associated with dyspnoea,
fatigue and decreased physical activity. Regular physical
activity in patients with COPD is associated with a lower
risk of admissions and mortality [2]. Most previous stud-
ies reported on physical activity during day time solely
[3–6]. When physical activity was measured over the
course of the day, nuanced reporting on physical activity
during different parts of the day was generally lacking* Correspondence: a.r.van_buul@lumc.nl
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tivity in COPD patients during the night and early
morning. Studying physical activity during the course of
the day is important, because a symptomatic start to the
day might influence physical activity during the rest of
the day.
Patients with COPD experience the morning as most
symptomatic part of the day [11, 12] and the night as sec-
ond most symptomatic part of the day [12]. Studies have
shown that morning symptoms are negatively associated
with self-reported physical activity [13]. A negative associ-
ation between morning symptoms and overall physical
activity has been reported [14]. However, the relation
between morning symptoms and objectively measured
physical activity during different parts of the day has notle is distributed under the terms of the Creative Commons Attribution 4.0
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morning symptoms influence self-care, housework and
work activities [15]. We hypothesized that patients with
high morning symptom scores are less active in the morn-
ing and during the rest of the day compared to patients
with low morning symptom scores. Furthermore, detailed
assessments of physical activity over the day could give
insight which part might be most suitable for physical ac-
tivity interventions. Therefore, the primary aim of this
study was to examine physical activity during the course
of the day depending on morning symptoms. In addition,
self-reported physical activity was assessed to better
understand which types of activities were generally
undertaken.
Methods
Research design
The Morning symptoms in-Depth observAtional Study
(MODAS) was a single centre, observational, cross-
sectional study (study NL51951.058.15; www.toetsingon
line.nl). The study was conducted from September 2015
to February 2017. The medical ethics committee from
the Leiden University Medical Center (LUMC) approved
the study protocol.
Participants
Detailed inclusion/exclusion criteria have been reported
previously [14]. In summary, included in the study were
patients aged 40 to 80 years. A physician had diagnosed
them with COPD. They had moderate to very severe air-
flow limitation according to the Global initiative for Ob-
structive Lung Disease (GOLD) definitions [16]. Patients
were exacerbation-free for at least 2 months. They were
current or active smokers with at least 10 pack-years.
Main exclusion criteria were the diagnosis of asthma; sig-
nificant other lung disease, comorbidities and severe pain
syndromes that impair exercise capacity. Patients were re-
cruited from the LUMC and Alrijne hospital in Leiden
(The Netherlands). Patients who were considered to be
eligible were notified about the study by telephone or dur-
ing an outpatient visit. Furthermore, patients were re-
cruited by flyers in local papers. Eligible interested
patients received an information letter. If the patient
agreed to participate in the study, a study visit was sched-
uled. During the visit, written informed consent was
obtained.
Assessments
During the baseline visit, demographic data and comor-
bidities were obtained by a physician. Patients were
asked about their medication use and this was verified
with a medication overview of the pharmacy. COPD-
specific health-related quality-of-life, morning symptoms
severity, self-reported physical activity and pre- and post-bronchodilator pulmonary function were assessed at the
study center. After this visit, patients wore a triaxial accel-
erometer for seven consecutive days to objectively assess
physical activity. When the physical activity measurements
were finished, there was a follow-up telephone interview
to report possible adverse events.
Morning symptom severity was evaluated with the
PRO-Morning COPD Symptoms Questionnaire (pre-
morning doses assessment) [17]. This questionnaire con-
sists of six questions about dyspnoea, cough, sputum
production, wheezing, chest tightness and limitations in
the morning. Patients rated the severity of these symp-
toms with a Likert scale from 0 to 10 points. 0 for no
symptoms; 10 points for symptoms as bad as they can
imagine. The total score ranged from 0 to 60.
Physical activity was objectively measured with an ac-
celerometer (Dynaport MoveMonitor, McRoberts BV,
The Hague, the Netherlands) [18, 19]. This accelerom-
eter was worn on the waist during the entire day for
seven consecutive days resulting in real-life activity re-
cording. To give insight into physical activity over the
course of the day, days were divided in four parts of the
day of each 6 hours: night (00.00 to 06.00), morning
(06.00 to 12.00), afternoon (12.00 to 18.00) and evening
(18.00 to 00.00). Duration of activity (standing, shuffling
and walking) and inactivity (sitting and lying) in minutes
was registered. The number of steps was recorded per
part of the day and per hour. Patients were not allowed
to wear the accelerometer during bathing or showering.
The duration that the accelerometer was not worn was
automatically registered. A measurement was considered
valid when patients wore the accelerometer at least 90%
per part of the day. Averages of the outcomes of valid
parts of the day were calculated for each patient. Pa-
tients with only invalid parts of the day were excluded
from analysis.
Patients filled out the Dutch version of the international
physically activity questionnaire (IPAQ) [20]. In this ques-
tionnaire patients reported the number of minutes per day
and days per week they were physical active in a 7-day
period. Physical activity was categorized in four domains:
work, transport, housework or leisure time related. Pa-
tients who reported more than 960 min a day each day of
the week were excluded from this analysis in line with the
activity calculation instructions of the IPAQ.
The Charlson Co-morbidity index was used to evaluate
comorbidities (CCI) [21] and the three most common co-
morbidities were reported as percentage. COPD-specific
health-related quality-of-life was assessed with the St
George’s Respiratory Questionnaire (SGRQ), [22] health
status with the Clinical COPD Questionnaire (CCQ) [23]
and dyspnoea in daily living with the medical modified re-
search council (mMRC) [24]. All patients performed pre-
and post-bronchodilator spirometry following ERS/ATS
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ety) standards in the morning between 08.30 and 11.00
(Care Fusion, Masterscreen PFT). [25–27] In this study,
reported spirometry outcomes were post-bronchodilator
values. Forced volume in 1 second (FEV1) was expressed
in % predicted values (based on the Global Lung Function
Initiative 2012) [26].Fig. 1 Study flow diagramStatistical analysis
Descriptive data were reported as percentages, mean
values ± standard deviations (SD) for normal distributed
continuous variables and median with interquartile ranges
(IQR) for non-normal distributed continuous variables.
The study cohort was divided in two equal groups using
the median score on the PRO-morning COPD Symptoms
Questionnaire as cut-off. Differences in baseline character-
istics between the two groups were compared with an in-
dependent t-test for continuous normal distributed
variables; a Mann-Whitney U test for continuous non-
normal distributed variables and chi-square test for cat-
egorical variables.
Differences in steps during the total day were compared
between patients with low and high morning symptom
scores using an independent t-test. Difference in steps and
duration of (in)activity during different parts of the day
were compared using an independent t-test or Mann-
Whitney U test. To give an overview of the number of
steps over the course of the day, steps per hour were plot-
ted against hour of the day. Self-reported physical activity
was compared using a Mann-Whitney U test. An explora-
tive subgroup analysis was performed to examine long-
acting pulmonary medication use. Long-acting pulmonary
medication use was categorized in three groups: double
bronchodilation (combination of a long-acting beta2
agonist (LABA) and long-acting muscarinic antagonist
(LAMA)), a single bronchodilator (LABA or LAMA use)
or no use of long-acting pulmonary medication. The dif-
ference in mean number of steps in the morning was eval-
uated with a one way ANOVA.
Steps per hour were plotted against hour of the day for
patients with low and high dyspnoea scores in daily living
[16] to evaluate the impact of using a general symptom
questionnaire instead of a specific morning symptom
questionnaire to divide the study group.
A sensitivity analysis was performed to evaluate the im-
pact of adverse events during the study period; all patients
who reported an adverse events, defined as self-reported
illness or any somatic symptom for which the patient had
to visit a health care provider, were excluded from the
analyses.
For all analyses, a p-value of < 0.05 was considered sta-
tistically significant. Missing data was not replaced. We
used SPSS version 23 to perform the analyses.Results
Patients
From 168 eligible patients who received the patient infor-
mation form, 80 patients were included in the study and
79 patients had sufficient outcomes from accelerometry
for analyses (Fig. 1). Table 1 shows demographics and
baseline characteristics. Patients were (mean ± SD) 65.6 ±
8.8 years old and 53% were male. They had a mean FEV1
of 55 ± 17% predicted. Most patients were classified as
COPD GOLD D (40.5%) and B (27.8%). Mean morning
symptom score was 17.9 ± 11.8 with a range between 0
and 47. The median morning symptom score was 17.0
and was used as cut-off to separate the study cohort in
two equal groups (Table 1).
Physical activity
Seventy nine patients wore the accelerometer 7 consecu-
tive days. Thus, data from 553 days were collected from
these 79 patients. 95.8% of the night, 91.0% of the morn-
ing, 96.7% of the afternoon and 93.9% the evening
Table 1 Baseline characteristics
Characteristic All included patients
(N = 79)
Morning symptom
score < 17.0 (N = 41)
Morning symptom
score≥ 17.0 (N = 38)
Difference
(P-value)
Age in years, mean (SD) 65.6 (8.8) 66.4 (8.2) 64.7 (9.4) 0.38
Male, n (%) 42 (53) 25 (61) 17 (45) 0.15
Ethnicity Caucasian, n (%) 78 (99) 40 (98) 38 (100) 0.33
Current smoking, n (%) 21 (27) 8 (20) 13 (34) 0.14
Pack years, median [IQR] 37 [25–51] 34 [25–42] 41 [26–71] 0.06
In current employment, n (%) 21 (27) 12 (29) 9 (24) 0.58
BMI in kg/m2, mean (SD) 26.4 (5.1) 25.5 (4.8) 27.3 (5.3) 0.13
FEV1/FVC ratio, mean (SD) 45.5 (12.2) 45.6 (13.6) 45.5 (10.6) 0.99
FEV1% predicted, mean (SD) 55.2 (16.9) 57.2 (19.3) 53.0 (14.0) 0.28
Exacerbation in the previous year, n (%) 41 (52) 16 (39) 25 (66) 0.017
GOLD stage
A, n (%) 19 (24.1) 17 (41.5) 2 (5.3) < 0.001
B, n (%) 22 (27.8) 9 (22.0) 13 (34.2) 0.23
C, n (%) 6 (7.6) 6 (14.6) 0 (0.0) 0.014
D, n (%) 32 (40.5) 9 (22.0) 23 (60.5) < 0.001
CCQ total score, mean (SD) 2.1 (1.1) 1.4 (0.86) 2.8 (0.9) < 0.001
SGRQ total score, mean (SD) 43.0 (18.6) 32.1 (16.6) 54.8 (12.4) < 0.001
Long-acting bronchodilation
Use of one long-acting bronchodilator, n (%) 17 (21.5) 10 (24.4) 7 (18.4) 0.52
Use of two long-acting bronchodilators, n (%)) 58 (74.7) 28 (68.3) 31 (81.6) 0.18
No long-acting bronchodilator, n (%) 3 (3.8) 3 (7.3) 0 (0.0) 0.09
CCI score, median [IQR] 2 [1–3] 2 [1–3] 2 [1–3] 0.98
History of solid tumor without metastasis, n (%) 15 (19.0) 9 (22.0) 6 (15.8) 0.49
Cerebrovascular disease, n (%) 10 (12.7) 6 (14.6) 4 (10.5) 0.58
Uncomplicated diabetes mellitus, n (%) 9 (11.4) 3 (7.3) 6 (15.8) 0.24
BMI body mass index, CCI Charlson comorbidity index, CCQ clinical COPD questionnaire, FEV1 Forced expiratory volume in 1 s, FVC forced vital capacity, GOLD
global initiative for chronic obstructive lung disease, IQR interquartile range, SD standard deviation, SGRQ St George Respiratory Questionnaire
Table 2 Duration of different types of activity during the
morning, afternoon, evening and night (N = 79)
Activity Total duration in mean min (SD)
Morning Afternoon Evening Night
Active timea 85.5 (39.7) 112.4 (42.3) 57.2 (34.1) 8.8 (10.1)
Standing 54.9 (25.4) 67.8 (25.5) 38.7 (25.9) 6.1 (7.4)
Shuffling 8.7 (5.4) 11.6 (6.7) 5.2 (4.1) 0.8 (1.0)
Walking 22.0 (15.1) 33.0 (20.0) 13.2 (9.8) 1.9 (2.4)
Inactive timeb 271.6 (39.7) 246.7 (42.0) 302.0 (34.1) 351.1 (10.1)
Lying 150.6 (63.9) 42.9 (45.8) 105.7 (78.5) 327.3 (51.2)
Sitting 120.9 (44.7) 203.8 (45.6) 196.3 (72.4) 23.8 (43.3)
Not worn 2.9 (4.7) 1.0 (1.8) 0.9 (2.2) 0.2 (0.7)
aActive: standing, shuffling and walking combined
binactive: lying and sitting combined. SD: standard deviation
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included in the analysis. In each part of the day, most of
the time was spent in inactivity (Table 2).
Mean number of steps per day was (mean ± SD) 5686
± 3514. Patients with low morning symptom scores took
6598 ± 4243 steps a day; those with high morning symp-
tom scores 4727 ± 2209 steps a day (mean difference
1871, p = 0.017). Patients with high morning symptom
scores took significantly fewer steps during the morning
(mean difference 669, p = 0.030) and during the after-
noon (mean difference 1013, p = 0.015) than patients
with low morning symptom scores (Table 3). Patients
with low morning symptom scores were active for longer
during the afternoon (mean difference 19, p = 0.040) and
spent more minutes walking during the morning (mean
difference 8, p = 0.020) and afternoon (mean difference
11, p = 0.010). There were peaks in mean number of
van Buul et al. Respiratory Research  (2018) 19:49 Page 5 of 9steps at 15:00 (550 steps per hour) and at 12:00 (535 steps
per hour) (Fig. 2). When patients with low and high morn-
ing symptom scores were categorized on medication use,
there was no significant difference in mean number of
steps in the morning between the groups (p = 0.057)
(Additional file 1: Figure S1). When patients were catego-
rized on high and low mMRC score, there was a signifi-
cant difference in number of steps in the morning,
afternoon and evening (Additional file 2: Figure S2).Table 3 Differences in duration of activity during the night, morning
high morning symptom scores
Steps Night
Morning
Afternoon
Evening
Active time (in min, mean (SD) or median [IQR]) Night
Morning
Afternoon
Evening
Standing (in min, mean (SD) or median [IQR]) Night
Morning
Afternoon
Evening
Shuffling (in min, mean (SD) or median [IQR]) Night
Morning
Afternoon
Evening
Walking (in min, mean (SD) or median [IQR]) Night
Morning
Afternoon
Evening
Inactive time (in min, mean (SD) or median [IQR]) Night
Morning
Afternoon
Evening
Lying (in min, mean (SD) or median [IQR]) Night
Morning
Afternoon
Evening
Sitting (in min, mean (SD) or median [IQR]) Night
Morning
Afternoon
Evening
Night N = 78, morning N = 78, afternoon N = 79, evening N = 78
COPD chronic obstructive pulmonary disease, IQR interquartile range, SD standard dSelf-reported daily activities
Patients’ median [IQR] self-reported physical activity
was 715 [319;1448] minutes a week. Patients spent most
of their self-reported physical activity during leisure time
(Table 4). Patients with low morning symptom scores
spent significantly more time in transport and leisure
time activities than those with high morning symptom
scores. No significant differences were found for work,
housework activities and total activity., afternoon and evening between COPD patients with low and
Morning symptom
score < 17.0 (N = 41)
Morning symptoms
score≥ 17.0 (N = 38)
P-value
97 [50–173] 92 [50–138] 0.60
2117 (1552) 1448 (1069) 0.030
3196 (2352) 2183 (1025) 0.015
1145 (858) 943 (861) 0.30
6 [2–11] 6 [3–10] 0.76
91 (39) 79 (40) 0.18
122 (45) 102 (38) 0.040
52 [37–79] 42 [33–77] 0.19
3 [1;7] 4 [2;8] 0.62
56 (24) 53 (28) 0.61
71 (25) 64 (26) 0.23
40 (24) 37 (28) 0.59
0 [0;1] 1 [0;1] 0.77
9 (6) 8 (5) 0.33
12 (7) 11 (6) 0.44
5 [2;8] 4 [2;6] 0.32
13 [7–19] 9 [6–15] 0.11
26 (17) 18 (12) 0.020
38 (24) 27 (12) 0.010
15 (10) 12 (10) 0.23
354 [349–358] 354 [350–357] 0.88
265 (40) 278 (39) 0.14
238 (44) 257 (37) 0.043
299 (33) 305 (36) 0.41
343 [322–353] 343 [330–355] 0.89
140 (52) 161 (74) 0.15
27 [5–50] 34 [12–68] 0.14
90 [44–138] 83 [53–151] 0.71
9 [3–22] 10 [2–22] 0.74
125 (38) 117 (51) 0.45
203 (41) 205 (51) 0.85
198 (68) 195 (78) 0.86
eviation
Fig. 2 Steps during each hour of the day, Low morning symptom
score: score < 17.0; high morning symptom score: score≥ 17.0
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Seven patients reported an adverse event. One patient was
exhausted due to the study visit, two patients reported
pain in their hands, one had pneumonia, one had flu, one
had sinusitis and one patient reported a visit to her gen-
eral practitioner who prescribed a course of antibiotics
and prednisone for pulmonary complaints. There were no
serious adverse events.
Patients with adverse events have a significant lower
quality of life and reported higher morning symptom
scores (Additional file 3: Table S1). When excluding the
patients with an adverse event from analyses, the cut-off n
the PRO-morning COPD Symptoms Questionnaire to
divide the cohort in two equal groups decreased to 15.0,
since all patients with an adverse event were categorized
in the high morning symptom score group. Results were
nearly similar (Additional file 3: Table S2 and S3 and
Additional file 4: Figure S3) apart from that there was noTable 4 Self-reported daily activities
IPAQ Total
(N = 7
Work, in min/week, median [IQR] 0 [0;0
Transport, in min/week, median [IQR] 155 [1
Housework, house maintenance and caring for family, in min/week,
median [IQR]
120 [0
Recreation, sport and leisure time in min/week, median [IQR] 160 [0
Total activity min/week, median [IQR] 715 [2
1448]
a9 out of 79 patients were excluded: 6 patients did not fully complete the IPAQ; 3 p
960 min a day each day of the week)
IPAQ international physical activity questionnaire, IQR interquartile rangedifference anymore in number of steps in the morning be-
tween patients with low and high morning symptom
scores.
Discussion
This study was designed to evaluate physical activity dur-
ing the course of the day in patients with moderate to se-
vere COPD with low and high morning symptom scores.
This is one of the first studies that explored physical activ-
ity in more detail during the course of the day using ob-
jective methodology. We showed that patients with high
morning symptom scores took significantly fewer steps in
the morning and afternoon than those with low morning
symptom scores. There were no differences in physical ac-
tivity in the evening and night between these two groups.
Patients with high morning symptom scores spent less
time in transport and leisure time than patients with low
morning symptom scores.
The present study showed that patients with high morn-
ing symptom scores took fewer steps during the total day.
This is in line with previous studies that have shown that
daily symptoms were associated with lower physical activ-
ity levels [10]. One study in a primary care setting in men
who are aged between 71 and 92 years, of whom 50% had
chronic conditions, [28] reported that men were most ac-
tive in the morning, followed by a substantial decline in
steps per hour, with peaks at times 10:00, 14:00 and 22:00.
Our study showed that the afternoon is the most active
part of the day for patients with COPD with peaks in steps
per hour at times 12:00 and 15:00. Thus, patients with
COPD have different activity patterns during the course of
the day. These findings are in line with another study
of activity in COPD patients; this study showed the
highest activity levels during the late morning and
early afternoon, followed by a decline in activity [5].
The difference in activity patterns between older men
and COPD patients could possibly be explained by
known activity characteristics that are typical for COPD
patients: lower walking speed, [29] walking with increased0)a
Morning symptom score
< 17.0 (N = 34)
Morning symptom score
≥ 17.0 (N = 36)
Difference
(p-value)
] 0 [0;30] 0 [0;0] 0.13
1–319] 195 [53–514] 68 [0–270] 0.047
–608] 105 [0–495] 150 [0–698] 0.89
–420] 293 [15–604] 60 [0–263] 0.017
19– 935 [533–1808] 665 [131–1298] 0.13
atients filled out unreasonably high time in physical activity (more than
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slower, [12] taking more breaks, [12] performing daily ac-
tivities in fewer bouts [4] and shorter bouts [4].
When analysing the activity patterns in a more de-
tailed way, the present study showed that patients with
high morning symptom scores were less active during
the morning and afternoon than patients with low
morning symptom scores. Systematic reviews have
shown that multiple determinants have impact on phys-
ical activity [31] and that morning symptoms are associ-
ated with physical activity [13]. The etiology of morning
symptoms is unknown. It can be speculated that inactiv-
ity in the afternoon in patients with high morning symp-
tom scores could be due to the long-lasting effects of
morning symptoms. It could also be true that patients
with morning symptoms have more symptoms during
the rest of the day [32]. Interestingly, we found no differ-
ence in active time during the evening and night be-
tween patients with low and high morning symptom
scores. We did not expect this, because we expected that
morning symptoms would be associated with less phys-
ical activity during each part of the day as patients re-
ported in previous studies in which physical activity was
not objectively measured [15, 33]. Exploring the assump-
tion that morning symptoms influence physical activity
in the morning, but not in the evening, the evening
might be a suitable part of the day in which physical ac-
tivity could be enhanced, especially in those with high
morning symptom scores.
In line with previous research, the present study
showed that patients spent most of their self-reported
physical activity in leisure time [4]. Patients with high
morning symptom scores spent less time in transport
and leisure time activities than patients with low morn-
ing symptom scores. Encouraging physical activity in
leisure time might result in more physical activity and
can also increase quality of life [34]. A few previous
studies have shown that inhaled medication decreased
physical activity limitations due to morning symptoms
[15, 35, 36]. An explorative analysis in the present study
showed no differences in physical activity between no,
single or double long-acting bronchodilator use. How-
ever, this study was not powered to show differences in
medication use and future research regarding this topic
is warranted.
A strength of the current study was 24-h a day
accelerometry. This resulted in real-life activity re-
cording without missing physical activity during the
evening and the night. However, we did not have in-
formation regarding the time patients go to bed and
woke up. Consequently, patients who got out of bed
early in the morning (and were already awake for a
couple of hours), were compared with patients who
had only just awoken. Previous studies that assessedthe association between morning symptoms and phys-
ical activity used self-reported questionnaires, while
accelerometers are superior in physical activity assess-
ment than questionnaires [13, 37]. Another strength
was the inclusion of patients from an academic med-
ical center, a local hospital and patients recruited by
flyers in local papers. This resulted in a heteroge-
neous population that is generalizable to all patients
with moderate to very severe COPD. A limitation of
the study was that the accelerometer was not water-
proof and patients were not allowed to wear it while
taking a shower. For some patients, taking a shower
is one of the main physical activities during a day,
and this activity was not measured. This means, ac-
tive time was underestimated. A second limitation is
that morning symptoms were evaluated with a non-
validated questionnaire. However, there is no validated
morning symptom questionnaire available yet. Patients
filled in the questionnaire at the study center and not
at home at the time they woke up. This might have
result in recall bias that might cause higher (or lower)
total morning symptom scores. The mean morning
symptom score was slightly higher than in a previous
study that used the PRO-Morning COPD Symptoms
Questionnaire too [17]. Therefore, it could be possible
that the cut-off point to separate high from low
morning symptom scores was too high. However,
when patients with an AE were removed and the cut-
off point dropped to 15.0, the outcomes were nearly the
same. Another limitation is the observational design of
the study. Therefore, it is not possible to prove whether
morning symptoms are fully responsible for the differ-
ences in physical activity or that physical inactivity itself
resulted in more symptoms due to muscle depletion and
loss of physical condition.
The ERS reported in the physical activity statement
in COPD that there are only a few randomised con-
trolled trials that studied effects of treatment on
physical activity and that there is a need for add-
itional well-designed trials [29]. Taking the outcomes
of this study into account, we suggest for future re-
search to focus on two targets to improve physical
activity: first, study the etiology of morning symptoms
It would be valuable to measure night time symp-
toms, the effect of flow-limitation during the night
(and the early morning) and the effects of spreading
physical activity in relation to morning symptoms.
Improvement in morning symptoms consequently
might increase the number of steps in the morning
and afternoon. Second, develop activity programs that
encourage physical activity in the evening in addition
to daily physical activities. Physical activity programs
can be supported by telecoaching and step counters
that provide direct feedback [3].
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This study showed that patients with moderate to
very severe COPD were most active in the afternoon.
Patients with high morning symptom scores took sig-
nificantly fewer steps in the morning and afternoon
than those with low morning symptom scores. Pro-
spective studies are needed to prove causality between
morning symptoms and physical activity during differ-
ent parts of the day.
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